You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameAcetylsalicylic acid
Accession NumberDB00945  (APRD00264, EXPT00475)
TypeSmall Molecule
GroupsApproved
Description

The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Acetylsalicylic acid also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)

Structure
Thumb
Synonyms
SynonymLanguageCode
2-(ACETYLOXY)benzoic acidNot AvailableNot Available
2-Acetoxybenzenecarboxylic acidNot AvailableNot Available
2-Acetoxybenzoic acidNot AvailableNot Available
AcetylsalicylateNot AvailableNot Available
Acetylsalicylic acidNot AvailableNot Available
AcetylsalicylsaeureNot AvailableNot Available
Acide 2-(acetyloxy)benzoiqueNot AvailableNot Available
Acide acétylsalicyliqueFrenchINN
ácido acetilsalicílicoSpanishINN
Acidum acetylsalicylicumLatinINN
ASANot AvailableNot Available
AspirinNot AvailableUSAN
AzetylsalizylsaeureNot AvailableNot Available
AzetylsalizylsäureGermanNot Available
EasprinNot AvailableNot Available
o-acetoxybenzoic acidNot AvailableNot Available
O-acetylsalicylic acidNot AvailableNot Available
o-carboxyphenyl acetateNot AvailableNot Available
PolopirynaPolishNot Available
Salicylic acid acetateNot AvailableNot Available
Prescription ProductsNot Available
Generic Prescription ProductsNot Available
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Ascriptin Maximum Strength Buffered Aspirintablet, film coated500 mgoralNovartis Consumer Health, Inc.2009-12-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Ascriptin Regular Strength Buffered Aspirintablet, film coated325 mgoralNovartis Consumer Health, Inc.2009-09-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bufferin LOW DOSE BUFFERED ASPIRINtablet81 mgoralNovartis Consumer Health, Inc.2011-03-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirintablet, chewable81 mgoralL. Perrigo Company1999-08-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirintablet, chewable81 mgoralL Perrigo Company1997-08-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirintablet, film coated81 mgoralL Perrigo Company1993-07-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirintablet325 mgoralL. Perrigo Company1991-04-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirintablet, chewable81 mgoralL. Perrigo Company1992-11-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Sense Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralL Perrigo Company1993-09-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Smart Health Aspirin regular strengthtablet325 mgoralL Perrigo Company2003-04-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Genuine Aspirintablet325 mgoralBayer Health Care Consumer Care2014-07-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Plus Extra Strengthtablet, coated500 mgoralBayer Health Care Llc, Consumer Care2015-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orangetablet, chewable81 mgoralBayer Health Care Llc, Consumer Care2015-01-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavoredtablet, chewable81 mgoralBayer Health Care Llc2002-07-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Low Dosetablet81 mgoralBayer Health Care Llc, Consumer Care2002-07-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Aspirin Regimen Regular Strengthtablet, chewable325 mgoralBayer Health Care Llc, Consumer Care2015-01-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Womenstablet, coated81; 777 mg/1; mgoralBayer Health Care Llc, Consumer Care2015-01-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Fast Releasepowder500 mgoralBayer Corporation Consumer Care Division2010-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Advanced Aspirin Regular Strengthtablet325 mgoralBayer Corporation Consumer Care Division2010-12-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Advanced Aspirin Extra Strengthtablet500 mgoralBayer Health Care Llc, Consumer Care2012-12-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirintablet325 mgoralWALGREEN CO.1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Tri-buffered Aspirintablet, film coated325 mgoralWALGREEN CO.1990-03-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralWALGREEN CO.1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Safety Coated Enteric Aspirintablet, coated325 mgoralWALGREEN CO.1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralWALGREEN CO.2001-09-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralWALGREEN CO.2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Low Dose Aspirintablet, coated81 mgoralWALGREEN CO.2004-04-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Low Dose Aspirintablet81 mgoralWALGREEN CO.2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, coated81 mgoralWALGREEN CO.2009-03-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coated Low Dosetablet81 mgoralWALGREEN CO.2014-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Henry Schein Aspirintablet, film coated325 mgoralHenry Schein, Inc.2011-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 ngoralLiberty Pharmaceuticals, Inc.2012-04-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Aspirintablet, delayed release81 mgoralLiberty Pharmaceuticals, Inc.2007-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
North Aspirintablet325 1oralNorth Safety Products2011-11-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralRUGBY LABORATORIES, INC2014-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Rugby Aspirintablet, chewable81 mgoralRugby Laboratories2014-03-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralRugby Laboratories1993-08-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralRugby Laboratories Inc.2008-04-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralRugby Laboratories Inc.1998-01-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Micro-coated Aspirintablet, coated325 mgoralRUGBY LABORATORIES, INC2011-09-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet, delayed release325 mgoralRUGBY LABORATORIES, INC2011-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirinsuppository300 mgrectalPaddock Laboratories, LLC1990-09-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirinsuppository600 mgrectalPaddock Laboratories, LLC1990-09-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralQualitest Pharmaceutical, Inc.2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralQualitest Pharmaceutical, Inc.2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralQualitest Pharmaceutical, Inc.2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralNcs Health Care Of Ky, Inc Dba Vangard Labs2009-09-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralNcs Health Care Of Ky, Inc Dba Vangard Labs2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralNcs Health Care Of Ky, Inc Dba Vangard Labs2010-08-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular Strength regular strengthtablet325 mgoralMajor Pharmaceuticals2006-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralMajor Pharmaceuticals Inc2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralMajor Pharmaceuticals Inc2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Tri-buffered Aspirintablet, film coated325 mgoralMajor Pharmaceuticals1990-03-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Thin coatedtablet325 mgoralMajor Pharmaceuticals2014-05-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralMajor Pharmaceuticals2007-12-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralMajor Pharmaceuticals2010-07-16Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspir Lowtablet81 mgoralMajor Pharmaceuticals2011-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Formucare Aspirintablet, delayed release81 mgoralAccess Business Group International LLC2006-02-27Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
7 Select Adult Chewable Aspirintablet, chewable81 mgoral7 Eleven2014-08-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
7 Select Aspirintablet325 mgoral7 Eleven2014-08-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Fasprintablet, orally disintegrating81 mgoralNobel Laboratories, LLC2006-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralSunrise Pharmaceutical Inc2005-12-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralSunrise Pharmaceutical Inc2010-01-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety-Coatedtablet81 mgoralTarget Corporation2013-03-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, coated325 mgoralTarget Corporation2011-04-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low-dose Aspirintablet81 mgoralTarget Corporation2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pain Relief Aspirintablet325 mgoralRite Aid2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Buffered Aspirintablet325 mgoralRite Aid1990-03-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralRite Aid2001-09-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralRite Aid2004-04-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Pain Relief Aspirintablet81 mgoralRite Aid2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Pain Relieftablet, coated325 mgoralRite Aid1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Safety Coated Aspirintablet, coated81 mgoralRite Aid2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pain Relief Aspirintablet, chewable81 mgoralRite Aid1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pain Relief Aspirin Low Dosetablet, coated81 mgoralRite Aid2014-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 goralApotheca, Inc1983-04-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralStephen L. La France Pharmacy, Inc.2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralStephen L. La France Pharmacy, Inc.1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralStephen L. La France Pharmacy, Inc.1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralStephen L. La France Pharmacy, Inc.2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Aspirintablet, delayed release81 mgoralPharbest Pharmaceuticals, Inc.2007-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pharbest Aspirin 325mgtablet, delayed release325 mgoralPharbest Pharmaceuticals, Inc.2010-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pharbest Regular Strength Aspirintablet325 mgoralPharbest Pharmaceuticals, Inc2007-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralPharbest Pharmaceuticals, Inc.2007-08-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralAdvance Pharmaceutical Inc.1988-04-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralAdvance Pharmaceutical Inc.2002-01-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralAdvance Pharmaceutical Inc.1990-05-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralAdvance Pharmaceutical Inc.1999-06-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralSafeway2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspiringtablet, chewable81 mgoralSafeway1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralSafeway2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralSafeway2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralRebel Distributors Corp2008-11-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Ectablet, coated81 mgoralRebel Distributors Corp1993-01-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirintablet, chewable81 mgoralAmerisource Bergen1993-03-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirintablet, chewable81 mgoralAmerisource Bergen1997-06-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirin orange flavor chewabletablet, chewable81 mgoralAmerisource Bergen2002-02-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirintablet325 mgoralAmerisource Bergen1989-09-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin regular strengthtablet, coated325 mgoralAmerisource Bergen Drug Corporation (Good Neighbor Pharmacy) 243852011-11-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralAmerisource Bergen1994-03-29Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Good Neighbor Pharmacy Aspirintablet, film coated81 mgoralAmerisource Bergen2004-10-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Flanax Aspirin Pain Relievertablet325 mgoralBelmora LLC2012-12-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralThe Kroger Co.2013-03-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralThe Kroger Co.2011-08-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralThe Kroger Co.2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dosetablet, chewable81 mgoralKroger Company1997-06-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralThe Kroger Co.2011-01-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular Strengthtablet325 mgoralKroger Company1987-11-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralThe Kroger Co2004-02-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralKroger Company1992-10-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Aspirintablet, delayed release81 mgoralAidarex Pharmaceuticals LLC2007-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralAidarex Pharmaceuticals LLC2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralASSURED / DOLLAR TREE (Greenbrier International, Inc.)2013-03-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralLake Erie Medical DBA Quality Care Products LLC2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Zee Aspirintablet325 mgoralZee Medical Inc2012-06-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralTOP CARE (Topco Associates LLC)2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin enteric safety coatedtablet81 mgoralTOP CARE (Topco Associates LLC)2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Topcare Aspirintablet, chewable81 mgoralTopco Associates LLC2006-04-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Topcare Aspirintablet, chewable81 mgoralTopco Associates LLC2005-03-29Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Topcare Aspirintablet, film coated81 mgoralTopco Associates LLC2005-05-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Topcare Aspirintablet, chewable81 mgoralTopco Associates LLC1992-08-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Aspirintablet325 mgoralCardinal Health1990-05-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralCardinal Health1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Aspirintablet, coated325 mgoralCardinal Health2012-04-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Aspirintablet, chewable81 mgoralCardinal Health1993-08-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Cardinal Health Aspirintablet, delayed release81 mgoralCardinal Health2001-08-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralCardinal Health2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Aspirintablet, chewable81 mgoralCardinal Health1997-04-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralCardinal Health (Leader)2013-04-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralH E B1991-09-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralH E B2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralH E B1998-02-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin adult low strengthtablet, film coated81 mgoralH E B2005-03-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Rx Act Aspirintablet, chewable81 mgoralH E B1997-05-29Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralH E B2004-08-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin 81 Mgtablet, coated81 mgoralH E B2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralSUPERVALU INC.2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, chewable81 mgoralSUPERVALU INC.1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equaline Aspirin adult low dosetablet, chewable81 mgoralSupervalu Inc2004-08-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin regular strengthtablet, coated325 mgoralSuper Valu (Equaline)2011-12-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Adult Low Dose Aspirintablet, chewable81 mgoralSUPERVALU INC.2001-09-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralSUPERVALU INC.2004-01-142015-10-15Us 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equaline Aspirintablet325 mgoralSupervalu Inc2004-08-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equaline Aspirintablet, chewable81 mgoralSupervalu Inc2004-08-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralSUPERVALU INC.2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet81 mgoralSUPERVALU INC.2014-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Kroger Value Aspirintablet325 mgoralKroger Company2007-03-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular Strengthtablet, coated325 mgoralMeijer2014-11-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralMeijer Distribution Inc1996-11-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated81 mgoralMeijer Distribution Inc1992-06-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralMEIJER, INC.2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin regular strengthtablet325 mgoralMeijer Distribution Inc1987-07-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralMeijer Distribution Inc1992-08-27Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralMeijer Distribution Inc1993-08-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin 81 Mg Low Dosetablet, coated81 mgoralMeijer2011-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin 81 Mgtablet, delayed release81 mgoralMeijer2014-11-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralHannaford Brothers Company1995-06-27Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, delayed release81 mgoralHannaford Brothers Company2005-04-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralCare One (American Sales Company)2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Safety Coated Aspirintablet81 mgoralCare One (American Sales Company)2010-07-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety Coatedtablet81 mgoralCare One (American Sales Company)2014-04-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Care One Aspirintablet, chewable81 mgoralAmerican Sales Company2005-11-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular strengthtablet, coated325 mgoralCare One (American Sales Company)2011-08-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Care One Aspirintablet325 mgoralAmerican Sales Company2004-05-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralCare One (American Sales Company)2010-07-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Care One Aspirintablet, chewable81 mgoralAmerican Sales Company2004-06-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet, delayed release325 mgoralRebel Distributors Corp2011-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralHy Vee2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralHy Vee Inc1997-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Safety Coatedtablet, coated325 mgoralHy Vee2014-05-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralHy Vee Inc1995-11-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralHy Vee Inc1997-06-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Value Pharma Aspirin Pain Relievertablet81 mg/81mgoralAjes Pharmaceuticals,LLC2012-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Value Pharma Aspirin Pain Relievertablet81 mg/81mgoralAjes Pharmaceuticals,LLC2012-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Value Pharmapain Reliever Extra Strengthtablet325 mg/325mgoralAjes Pharmaceuticals,LLC2012-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Value Pharmapain Reliever Extra Strengthtablet325 mg/325mgoralAjes Pharmaceuticals,LLC2012-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralAmerisource Bergen (Good Neighbor Pharmacy)2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Adult Low Strength Aspirintablet, coated81 mgoralAmerisource Bergen (Good Neighbor Pharmacy)2011-03-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralAmerisource Bergen (Good Neighbor Pharmacy) 461222014-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralSave A Lot Food Stores, Ltd.2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralSave A Lot Food Stores, Ltd.2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Medique Aspirintablet, film coated325 mgoralUnifirst First Aid Corporation2008-12-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Medi-first Aspirintablet, film coated325 mgoralUnifirst First Aid Corporation2008-12-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Medi First Plus Aspirintablet, film coated325 mgoralUnifirst First Aid Corporation2008-12-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayer Genuine Aspirintablet, coated325 mgoralUnifirst First Aid Corporation2014-01-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose chewabletablet, chewable81 mgoralSafecor Health, LLC2014-09-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralSafecor Health, LLC2014-09-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralWal Mart Stores Inc2014-02-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equate Aspirin chewabletablet, chewable81 mgoralWal Mart Stores Inc2003-03-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin regular strengthtablet, coated325 mgoralEQUATE (Walmart Stores, Inc.)2013-10-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equate Aspirintablet325 mgoralWal Mart Stores Inc1990-02-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Equate Aspirintablet, chewable81 mgoralWal Mart Stores Inc2003-03-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralWal Mart Stores Inc2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirintablet, coated325 mgoralWal Mart Stores Inc1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Adult Low Dosetablet, coated81 mgoralWal Mart Stores Inc2014-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirin Regular Strengthtablet325 mgoralMc Kesson2003-06-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirintablet, chewable81 mgoralMc Kesson2003-09-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirin adult low strengthtablet, chewable81 mgoralMc Kesson2003-09-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirin adult low strengthtablet, film coated81 mgoralMc Kesson2004-09-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirin low dosetablet, delayed release81 mgoralMc Kesson2003-08-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Sunmark Aspirintablet, chewable81 mgoralMc Kesson2003-08-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular strengthtablet, coated325 mgoralMc Kesson (Sunmark)2010-09-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralMc Kesson2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralMc Kesson2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralTIME CAP LABS INC2014-04-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release325 mgoralTIME CAP LABORATORIES INC.2012-05-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Miniprintablet, coated81 mgoralTIME CAP LABORATORIES, INC2012-05-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralTime Cap Labs, Inc2010-08-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Miniprin Enteric Safety Coatedtablet, delayed release81 mgoralTime Cap Labs, Inc2010-08-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular Strengthtablet, delayed release325 mg/3251oralTime Cap Labs, Inc2011-01-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose chewabletablet, chewable81 mgoralTime Cap Labs, Inc2010-07-16Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Delayed Releasetablet, delayed release81 mg/811oralTime Cap Labs, Inc2010-12-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralTime Cap Labs, Inc2010-08-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin EXTRA STRENGTHtablet, coated500 mg/5001oralTime Cap Labs, Inc2013-02-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose enteric coatedtablet, coated81 mgoralTime Cap Labs, Inc2010-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose enteric coatedtablet81 mgoralTime Cap Labs, Inc2010-07-16Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin adult low dosetablet, chewable81 mgoralMedicine Shoppe International Inc1997-05-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, coated81 mgoralMedicine Shoppe International Inc2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet81 mgoralAmerica Medic2012-05-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Enteric Coatedtablet81 mgoralSMART SENSE (Kmart)2013-03-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Smart Sense Aspirintablet, chewable81 mgoralKmart Corporation2010-06-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Smart Sense Aspirintablet, film coated81 mgoralKmart Corporation2010-10-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Smart Sense Aspirintablet325 mgoralKmart Corporation2010-06-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Smart Sense Aspirintablet, chewable81 mgoralKmart Corporation2010-06-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Low Dose Aspirintablet, chewable81 mgoralCardinal Health2014-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Leader Aspirintablet, chewable81 mgoralCardinal Health2014-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralCardinal Health2014-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralCardinal Health2014-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralCardinal Health2014-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pharbest Regular Strength Aspirintablet325 mgoralA S Medication Solutions Llc2007-01-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Pharbest Aspirin 325mgtablet, delayed release325 mgoralA S Medication Solutions Llc2010-09-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralHART Health1986-06-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspir Lowtablet81 mgoralUnit Dose Services2011-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspir Lowtablet81 mgoralUnit Dose Services2011-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralGeiss, Destin & Dunn, Inc (Goodsense)2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular strengthtablet, coated325 mgoralGood Sense (Geiss, Destin & Dunn, Inc.)2011-08-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralL.N.K. International, Inc.2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Enteric Aspirintablet, coated325 mgoralL.N.K. International, Inc.1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralL.N.K. International, Inc.1993-08-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralL.N.K. International, Inc.2011-05-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspi-cortablet, coated81 mgoralL.N.K. International, Inc.2015-02-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Critical Care Aspirin To Gopowder325 mgoralBreakthrough Products Inc.2012-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Plus Pharma Nsaid Aspirintablet325 mgoralGemini Pharmaceuticals, Inc. dba Plus Pharma2006-03-27Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, extended release81 mgoralGemini Pharmaceuticals, Inc. dba Plus Pharmaceuticals2013-01-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralNew World Imports, Inc2011-08-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralNew World Imports, Inc2011-01-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralGenuine First Aid LLC2010-04-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Aspirintablet, chewable81 mgoralGenuine First Aid LLC2010-04-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralCispharma, Inc2011-02-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralCispharma, Inc2010-11-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralH.J. Harkins Company, Inc.2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralState of Florida DOH Central Pharmacy2014-11-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular Strength regular strengthtablet325 mgoralA S Medication Solutions Llc2006-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralPhysicians Total Care, Inc.1995-02-27Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin ECtablet, coated325 mgoralPhysicians Total Care, Inc.1993-09-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin ECtablet, coated81 mgoralPhysicians Total Care, Inc.2000-11-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralPhysicians Total Care, Inc.2007-11-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular Strengthtablet, delayed release325 mg/3251oralCardinal Health2013-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralCardinal Health2012-11-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralCardinal Health2012-11-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspir Lowtablet81 mgoralCardinal Health2011-05-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular Strengthtablet, delayed release325 mg/3251oralCardinal Health2013-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralArmy and Air Force Exchange Service1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirintablet, coated325 mgoralArmy and Air Force Exchange Service1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralArmy and Air Force Exchange Service2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, coated81 mgoralArmy and Air Force Exchange Service2011-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Chewable Low Dose Aspirintablet, chewable81 mgoralArmy and Air Force Exchange Service1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralWestern Family Foods, Inc.2013-03-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin enteric safety coatedtablet81 mgoralWestern Family Foods, Inc.2012-01-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Safety Coatedtablet, coated81 mgoralWestern Family Foods, Inc.2014-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin adult low strengthtablet, chewable81 mgoralWestern Family Foods Inc2001-09-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Adult Low Strengthtablet, film coated81 mgoralWestern Family Foods Inc2004-05-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, delayed release81 mgoralWestern Family Foods, Inc.2012-01-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralWestern Family Foods Inc1993-03-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, delayed release81 mgoralWestern Family Foods Inc2003-07-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, coated81 mgoralFreds Inc2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Safety coatedtablet, coated81 mgoralFreds Inc2014-08-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralFreds Inc2013-03-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, coated81 mgoralFRED'S, INC.2011-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralHealthy Accents (DZA Brands, LLC)2013-03-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Healthy Accents Aspirintablet, chewable81 mgoralDZA Brands LLC2011-06-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Healthy Accents Aspirintablet325 mgoralDZA Brands LLC2008-01-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Healthy Accents Aspirintablet, chewable81 mgoralDZA Brands LLC2008-02-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Healthy Accents Aspirintablet, delayed release81 mgoralDZA Brands LLC2008-03-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Low Dose Aspirintablet, chewable81 mgoralFamily Dollar1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirin 81 Mg Safety Coatedtablet, delayed release81 mgoralFamily Dollar (FAMILY WELLNESS)2014-07-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet81 mgoralFamily Dollar2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated325 mgoralMoore Medical LLC2008-12-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bufferintablet325 mgoralDucere Pharma LLC2013-05-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet81 mgoralPharmadel LLC2013-03-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Rexall Aspirintablet, chewable81 mgoralDolgencorp, LLC2010-08-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralDolgencorp, LLC2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralDolgencorp, LLC2004-04-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Dg Health Aspirintablet, chewable81 mgoralDolgencorp, LLC2009-12-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Asprintablet81 mgoralDolgencorp, LLC2011-05-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin 81 Mgtablet, coated81 mgoralDolgencorp, LLC2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety Coatedtablet, coated81 mgoralPublix Supermarkets, Inc.2013-08-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralPublix Super Markets Inc1999-07-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralPublix Super Markets Inc1998-08-24Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralPublix Super Markets Inc1988-09-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, coated81 mgoralPublix Supermarkets, Inc.2013-01-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralPublix Super Markets Inc1999-07-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralPublix Super Markets Inc2001-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralSalado Sales, Inc.2006-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release325 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralAAA Pharmaceutical, Inc.2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Nsaidtablet325 mgoralGeri Care Pharmaceutical1993-08-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralGeri Care Pharmaceutical1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Strength Chewable Aspirintablet, chewable81 mgoralGeri Care Pharmaceutical Corp1995-01-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Enteric Coated Aspirintablet, coated325 mgoralGeri Care Pharmaceutical Corp2000-07-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Enteric Coated Aspirintablet, coated81 mgoralGeri Care Pharmaceutical Corp2000-07-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose enteric coatedtablet, coated81 mgoralClinical Solutions Wholesale2010-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralClinical Solutions Wholesale2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralPure Tek Corporation2011-07-07Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralP And L Development Of New York Corporation (Ready In Case)2014-07-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralP And L Development Of New York Corporation (Ready In Case)2013-03-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, coated81 mgoralP and L Development of New York Corporation2010-09-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Safety Coatedtablet, coated325 mgoralCVS Pharmacy2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated325 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Buffered Aspirintablet, film coated325 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED1990-03-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Aspirintablet, chewable81 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enterictablet, coated325 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Uncoated Aspirintablet325 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED1993-08-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralCVS Pharmacy1997-02-20Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Genuine Aspirintablet325 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED2001-05-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED2004-01-142015-11-20Us 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Regular Strengthtablet325 mgoralCVS Pharmacy1991-06-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Aspirintablet, coated81 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED2004-04-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralCVS Pharmacy1992-08-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet81 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Strengthtablet, coated81 mgoralWOONSOCKET PRESCRIPTION CENTER,INCORPORATED2014-07-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Rapid Comfort Aspirintablet, film coated325 mgoralLab Safety Supply, Inc.2011-10-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralSt Marys Medical Park Pharmacy2014-05-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Direct Safety Aspirintablet, film coated325 mgoralConney Safety Products, LLC2013-05-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralPreferred Plus (Kinray)2013-03-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralDIRECT RX2014-01-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralMc Kesson2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release81 mgoralMc Kesson2012-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Mart Aspirintablet325 mgoralMc Kesson2011-11-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Mart Aspirintablet, chewable81 mgoralMc Kesson2011-11-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Mart Aspirintablet, chewable81 mgoralMc Kesson2011-11-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Mart Regular Strength Enteric Coated Aspirintablet, coated325 mgoralMc Kesson (Health Mart)2012-06-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Mart Aspirintablet, chewable81 mgoralMc Kesson2013-08-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Sense Adult Chewable Low Strength Aspirintablet, chewable81 mgoralPrime Marketing, LLC2006-10-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Sense Aspirin 81tablet, coated81 mgoralPrime Marketing, LLC2006-07-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Health Sense Ecpirintablet, coated325 mgoralPrime Marketing, LLC2006-12-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralA&Z Pharmaceutical, Inc.2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralA&Z Pharmaceutical, Inc.2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralA&Z Pharmaceutical, Inc.2007-06-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralA&Z Pharmaceutical Inc.2013-09-19Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralA&Z Pharmaceutical, Inc.2013-11-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Solves - Aspirin Cherrystrip81 mgoralPace Wellness Inc.2014-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Solves - Aspirin Cherrystrip81 mgoralPace Wellness Inc.2014-05-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Ecotrintablet, coated81 mgoralMedtech Products Inc.2012-06-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Ecotrin Regular Strengthtablet, coated325 mgoralMedtech Products Inc.2012-06-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Ecotrintablet, coated81 mgoralMedtech Products Inc.2012-06-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralAvema Pharma Solutions2011-08-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Asprintablet, delayed release81 mgoralAvema Pharma Solutions2010-01-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, delayed release325 mgoralbryant ranch prepack2012-05-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralbryant ranch prepack2008-04-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin low dose enteric coatedtablet, coated81 mgoralMc Kesson Packaging Services Business Unit Of Mc Kesson Corporation2012-11-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin Regular Strengthtablet, delayed release325 mg/3251oralMcKesson Packaging Services a business unit of McKesson Corporation2013-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Aspirintablet, chewable81 mgoralChain Drug Marketing Association2014-06-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralChain Drug Marketing Association Inc1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralQUALITY CHOICE (Chain Drug Marketing Association)2014-07-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Asprin 81 Mgtablet81 mgoralChain Drug Marketing Association Inc2011-05-02Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin 81 Mgtablet, delayed release81 mgoralChain Drug Marketing Association2014-06-13Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Aspirintablet325 mgoralChain Drug Marketing Association Inc1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralBest Choice (Valu Merchandisers Company)2014-06-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Nsaidtablet, film coated325 mgoralVALUE MERCHANDISERS COMPANY, INC.1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet81 mgoralBest Choice (Valu Merchandisers Company)2013-03-08Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralVALUE MERCHANDISERS COMPANY, INC.1993-08-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirin regular strengthtablet, coated325 mgoralBest Choice (Valu Merchandisers Company)2011-11-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Aspirintablet, chewable81 mgoralVALUE MERCHANDISERS COMPANY, INC.2001-09-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Adult low strengthtablet, delayed release81 mgoralValu Merchandisers Company (Best Choice)2010-07-26Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Safety Coated Aspirintablet81 mgoralValu Merchandisers Company (Best Choice)2010-08-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Aspirintablet, coated325 mgoralCostco Wholesale Corporation1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, coated81 mgoralCostco Wholesale Corporation2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet81 mgoralGREAT LAKES WHOLESALE, MARKETING, & SALES, INC.2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Aspirintablet, coated325 mgoralGREAT LAKES WHOLESALE, MARKETING, & SALES, INC.1992-12-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralGREAT LAKES WHOLESALE, MARKETING, & SALES, INC.1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, chewable81 mgoralGREAT LAKES WHOLESALE, MARKETING, & SALES, INC.1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Plus Pharma NSAID 325 mgtablet81 mgoralTYA Pharmaceuticals2014-09-29Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Enteric Coated Aspirintablet, coated81 mgoralTYA Pharmaceuticals2000-07-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated325 mgoralHIMPRIT PHARMACHEM PVT LTD2010-03-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Bayertablet325 mgoralLil' Drug Store Products, Inc.2009-07-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated325 mgoralContract Pharmacy Services Pa2010-08-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, film coated81 mgoralContract Pharmacy Services Pa2010-08-17Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, film coated325 mgoralContract Pharmacy Services Pa2010-11-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Chewabletablet, chewable81 mgoralContract Pharmacy Services Pa2010-08-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, film coated81 mgoralContract Pharmacy Services Pa2010-08-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, film coated81 mgoralContract Pharmacy Services Pa2010-08-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, film coated81 mgoralContract Pharmacy Services Pa2010-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralWin Co Foods, Llc1996-02-10Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Chewable Low Dosetablet, chewable81 mgoralWin Co Foods, Llc2014-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dosetablet, delayed release81 mgoralWin Co Foods, Llc2014-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Safety Coated Adult Low Dosetablet, delayed release81 mgoralWin Co Foods, Llc2014-12-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralKareway Product, Inc.2011-11-23Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Regular Strength Aspirin Ectablet, delayed release325 mgoralAphena Pharma Solutions Tennessee, Llc2011-09-09Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Ectablet, coated81 mgoralAphena Pharma Solutions Tennessee, Llc1994-02-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Handy Solutions Genuine Aspirin Bayertablet325 mgoralNavajo Manufacturing Company Inc.2013-08-21Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Enteric Coatedtablet, delayed release81 mgoralChain Drug Consortium, LLC (Premier Value)2011-03-22Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralPremier Value (Chain Drug Consortium, LLC)2013-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralCarilion Materials Management2009-11-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Chewable Adult Low Dose Aspirintablet, chewable81 mgoralRaritan Pharmaceuticals Inc2013-06-03Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Adult Aspirintablet81 mgoralSam's West Inc2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirin Low Dose Safety Coatedtablet, coated81 mgoralBJWC (Berkley & Jensen / BJ's)2013-03-31Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Ec-81aspirin Enteric Coatedtablet81 mgoralTri Marc Labs2010-08-11Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated81 mgoralPreferred Pharmaceuticals, Inc2010-06-28Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralPreferred Pharmaceuticals, Inc.2013-06-06Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralAllegiant Health2014-12-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Chewable Aspirintablet, chewable81 mgoralNash Finch Company1990-09-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Low Dose Aspirintablet, chewable81 mgoralNash Finch Company2001-09-04Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Enteric Coated Aspirintablet81 mgoralNash Finch Company2008-02-12Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet325 mgoralWinder Laboratories, LLC2011-08-25Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Dose Aspirin Enteric Safety Coatedtablet, delayed release81 mgoralZandi LLC2011-01-18Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
St. Joseph Chewable Aspirintablet, chewable81 mgoralIlex Consumer Products Group, LLC2012-03-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
St. Joseph Safety Coated Aspirintablet, coated81 mgoralIlex Consumer Products Group, LLC2012-03-05Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralBedrock Brands, LLC (ST. JOSEPH)2014-05-30Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet, coated325 mgoralILEX Consumer Products Group, LLC (ST. JOSEPH)2012-03-15Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Adult Low Strength Aspirintablet, coated81 mgoralIlex Consumer Products Group, LLC2004-01-14Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Aspirintablet81 mgoralVelocity Pharma2011-04-01Not AvailableUs 0a2ef1ad1c84951dc1392a8bbe1f3cb241c91ed59e44ad8268635315440d978c
Asaphentablet (chewable)80 mgoralPharmascience IncNot AvailableNot AvailableCanada 5f16b84899037e23705f146ff57e3794121879cb055f0954756d94bc690476b4
Novasentablet (delayed-release)325 mgoralTeva Canada LimitedNot AvailableNot AvailableCanada 5f16b84899037e23705f146ff57e3794121879cb055f0954756d94bc690476b4
Novasentablet (delayed-release)650 mgoralTeva Canada LimitedNot AvailableNot AvailableCanada 5f16b84899037e23705f146ff57e3794121879cb055f0954756d94bc690476b4
Entrophentablet (delayed-release)81 mgoralPendopharm Division Of De Pharmascience IncNot AvailableNot AvailableCanada 5f16b84899037e23705f146ff57e3794121879cb055f0954756d94bc690476b4
International Brands
NameCompany
AcenterineNot Available
AcetophenMerck
AdiroNot Available
AspergumNot Available
AsproNot Available
Bayer AspirinBayer HealthCare LLC.
EasprinNot Available
EmpirinNot Available
Nu-sealsNot Available
RhodineNot Available
RhonalNot Available
SolprinNot Available
Solprin acidNot Available
St. Joseph Aspirin for AdultsNot Available
TasprinNot Available
Brand mixtures
Brand NameIngredients
Aspirin with Stomach GuardAcetylsalicylic Acid + Calcium Carbonate + Magnesium Carbonate + Magnesium Oxide
Extra Strength Aspirin BackacheAcetylsalicylic Acid + Methocarbamol
SynalgosCaffeine + Acetylsalicylic acid + Dihydrocodeine
SaltsNot Available
Categories
CAS number50-78-2
WeightAverage: 180.1574
Monoisotopic: 180.042258744
Chemical FormulaC9H8O4
InChI KeyBSYNRYMUTXBXSQ-UHFFFAOYSA-N
InChI
InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)
IUPAC Name
2-(acetyloxy)benzoic acid
SMILES
CC(=O)OC1=CC=CC=C1C(O)=O
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as phenol esters. These are aromatic compounds containing a benzene ring substituted by a hydroxyl group and an ester group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenol esters
Direct ParentPhenol esters
Alternative Parents
Substituents
  • Phenol ester
  • Benzoic acid
  • Benzoic acid or derivatives
  • Benzoyl
  • Dicarboxylic acid or derivatives
  • Acetate salt
  • Carboxylic acid ester
  • Carboxylic acid
  • Carboxylic acid derivative
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Pharmacology
IndicationFor use in the temporary relief of various forms of pain, inflammation associated with various conditions (including rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and ankylosing spondylitis), and is also used to reduce the risk of death and/or nonfatal myocardial infarction in patients with a previous infarction or unstable angina pectoris.
PharmacodynamicsAcetylsalicylic acid is an analgesic, antipyretic, antirheumatic, and anti-inflammatory agent. Acetylsalicylic acid's mode of action as an antiinflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins. Acetylsalicylic acid appears to produce analgesia by virtue of both a peripheral and CNS effect. Peripherally, acetylsalicylic acid acts by inhibiting the synthesis and release of prostaglandins. Acting centrally, it would appear to produce analgesia at a hypothalamic site in the brain, although the mode of action is not known. Acetylsalicylic acid also acts on the hypothalamus to produce antipyresis; heat dissipation is increased as a result of vasodilation and increased peripheral blood flow. Acetylsalicylic acid's antipyretic activity may also be related to inhibition of synthesis and release of prostaglandins.
Mechanism of actionThe analgesic, antipyretic, and anti-inflammatory effects of acetylsalicylic acid are due to actions by both the acetyl and the salicylate portions of the intact molecule as well as by the active salicylate metabolite. Acetylsalicylic acid directly and irreversibly inhibits the activity of both types of cyclooxygenase (COX-1 and COX-2) to decrease the formation of precursors of prostaglandins and thromboxanes from arachidonic acid. This makes acetylsalicylic acid different from other NSAIDS (such as diclofenac and ibuprofen) which are reversible inhibitors. Salicylate may competitively inhibit prostaglandin formation. Acetylsalicylic acid's antirheumatic (nonsteroidal anti-inflammatory) actions are a result of its analgesic and anti-inflammatory mechanisms; the therapeutic effects are not due to pituitary-adrenal stimulation. The platelet aggregation-inhibiting effect of acetylsalicylic acid specifically involves the compound's ability to act as an acetyl donor to cyclooxygenase; the nonacetylated salicylates have no clinically significant effect on platelet aggregation. Irreversible acetylation renders cyclooxygenase inactive, thereby preventing the formation of the aggregating agent thromboxane A2 in platelets. Since platelets lack the ability to synthesize new proteins, the effects persist for the life of the exposed platelets (7-10 days). Acetylsalicylic acid may also inhibit production of the platelet aggregation inhibitor, prostacyclin (prostaglandin I2), by blood vessel endothelial cells; however, inhibition prostacyclin production is not permanent as endothelial cells can produce more cyclooxygenase to replace the non-functional enzyme.
AbsorptionAbsorption is generally rapid and complete following oral administration but may vary according to specific salicylate used, dosage form, and other factors such as tablet dissolution rate and gastric or intraluminal pH.
Volume of distributionNot Available
Protein bindingHigh (99.5%) to albumin. Decreases as plasma salicylate concentration increases, with reduced plasma albumin concentration or renal dysfunction, and during pregnancy.
Metabolism

Acetylsalicylic acid is rapidly hydrolyzed primarily in the liver to salicylic acid, which is conjugated with glycine (forming salicyluric acid) and glucuronic acid and excreted largely in the urine.

SubstrateEnzymesProduct
Acetylsalicylic acid
Not Available
1-Salicylate glucuronideDetails
Route of eliminationNot Available
Half lifeThe plasma half-life is approximately 15 minutes; that for salicylate lengthens as the dose increases: doses of 300 to 650 mg have a half-life of 3.1 to 3.2 hours; with doses of 1 gram, the half-life is increased to 5 hours and with 2 grams it is increased to about 9 hours.
ClearanceNot Available
ToxicityOral, mouse: LD50 = 250 mg/kg; Oral, rabbit: LD50 = 1010 mg/kg; Oral, rat: LD50 = 200 mg/kg. Effects of overdose include: tinnitus, abdominal pain, hypokalemia, hypoglycemia, pyrexia, hyperventilation, dysrhythmia, hypotension, hallucination, renal failure, confusion, seizure, coma, and death.
Affected organisms
  • Humans and other mammals
PathwaysNot Available
SNP Mediated Effects
Interacting Gene/EnzymeSNP RS IDAllele nameDefining changeEffectReference(s)
Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712
rs1057910 CYP2C9*1C AllelePoor drug metabolizer, lower dose requirements12893985
Integrin beta-3
Gene symbol: ITGB3
UniProt: P05106
rs5918 Not AvailableT > CPatients are more resistant to the anti-thrombotic effects of aspirin11723016
SNP Mediated Adverse Drug Reactions
Interacting Gene/EnzymeSNP RS IDAllele nameDefining changeAdverse ReactionReference(s)
Leukotriene C4 synthase
Gene symbol: LTC4S
UniProt: Q16873
rs730012 Not AvailableC alleleAspirin-induced urticaria16433794
ADMET
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9645
Blood Brain Barrier+0.9376
Caco-2 permeable-0.6607
P-glycoprotein substrateNon-substrate0.685
P-glycoprotein inhibitor INon-inhibitor0.9118
P-glycoprotein inhibitor IINon-inhibitor0.9615
Renal organic cation transporterNon-inhibitor0.914
CYP450 2C9 substrateNon-substrate0.7518
CYP450 2D6 substrateNon-substrate0.9116
CYP450 3A4 substrateNon-substrate0.7225
CYP450 1A2 substrateNon-inhibitor0.9046
CYP450 2C9 substrateNon-inhibitor0.9071
CYP450 2D6 substrateNon-inhibitor0.9576
CYP450 2C19 substrateNon-inhibitor0.9445
CYP450 3A4 substrateNon-inhibitor0.9611
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9557
Ames testNon AMES toxic0.9326
CarcinogenicityNon-carcinogens0.8356
BiodegradationReady biodegradable0.9067
Rat acute toxicity2.6386 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9433
hERG inhibition (predictor II)Non-inhibitor0.9799
Pharmacoeconomics
Manufacturers
  • Bayer healthcare llc
Packagers
Dosage forms
FormRouteStrength
Powderoral325 mg
Powderoral500 mg
Striporal81 mg
Suppositoryrectal300 mg
Suppositoryrectal600 mg
Tabletoral325 1
Tabletoral325 g
Tabletoral325 mg
Tabletoral325 mg/325mg
Tabletoral500 mg
Tabletoral81 mg
Tabletoral81 mg/81mg
Tablet (chewable)oral80 mg
Tablet (delayed-release)oral325 mg
Tablet (delayed-release)oral650 mg
Tablet (delayed-release)oral81 mg
Tablet, chewableoral325 mg
Tablet, chewableoral81 mg
Tablet, coatedoral325 mg
Tablet, coatedoral325 ng
Tablet, coatedoral500 mg
Tablet, coatedoral500 mg/5001
Tablet, coatedoral81 mg
Tablet, coatedoral81; 777 mg/1; mg
Tablet, delayed releaseoral325 mg
Tablet, delayed releaseoral325 mg/3251
Tablet, delayed releaseoral81 mg
Tablet, delayed releaseoral81 mg/811
Tablet, extended releaseoral81 mg
Tablet, film coatedoral325 mg
Tablet, film coatedoral500 mg
Tablet, film coatedoral81 mg
Tablet, orally disintegratingoral81 mg
Prices
Unit descriptionCostUnit
Entrophen 10 650 mg Enteric-Coated Tablet0.09USD tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
PatentsNot Available
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point135 °CPhysProp
boiling point140 °CNot Available
water solubility4600 mg/L (at 25 °C)YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP1.19HANSCH,C ET AL. (1995)
Caco2 permeability-5.06ADME Research, USCD
pKa3.49 (at 25 °C)MERCK INDEX (1983)
Predicted Properties
PropertyValueSource
Water Solubility1.46 mg/mLALOGPS
logP1.43ALOGPS
logP1.24ChemAxon
logS-2.1ALOGPS
pKa (Strongest Acidic)3.41ChemAxon
pKa (Strongest Basic)-7.1ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area63.6 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity44.45 m3·mol-1ChemAxon
Polarizability17.1 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Mass Spec (NIST)Download (8.27 KB)
SpectraGC-MSMS/MSMS1D NMR2D NMR
References
Synthesis Reference

Marino Gobetti, Guido Vandoni, “Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them.” U.S. Patent US4563443, issued March, 1981.

US4563443
General Reference
  1. Macdonald S: Aspirin use to be banned in under 16 year olds. BMJ. 2002 Nov 2;325(7371):988. Pubmed
  2. Sneader W: The discovery of aspirin: a reappraisal. BMJ. 2000 Dec 23-30;321(7276):1591-4. Pubmed
  3. Aukerman G, Knutson D, Miser WF: Management of the acute migraine headache. Am Fam Physician. 2002 Dec 1;66(11):2123-30. Pubmed
  4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug 13;2(8607):349-60. Pubmed
  5. Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, Colby E, Montague D, Smyth SS: Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother. 2007 May;41(5):737-41. Epub 2007 Apr 24. Pubmed
External Links
ATC CodesA01AD05B01AC06N02BA01
AHFS Codes
  • 28:08.04.24
  • 92:02.00*
PDB EntriesNot Available
FDA labelDownload (889 KB)
MSDSDownload (18.9 KB)
Interactions
Drug Interactions
Drug
AbciximabAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
AcarboseMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
AcenocoumarolAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
AcetazolamideMay enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.
AlbiglutideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
AlendronateAspirin may enhance the adverse/toxic effect of Alendronate. Specifically gastrointestinal adverse events.
AlogliptinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
AlteplaseMay enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.
Aminosalicylic AcidMay enhance the anticoagulant effect of other Salicylates.
Ammonium chlorideMay increase the serum concentration of Salicylates.
AnagrelideAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
AnistreplaseAgents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.
ApixabanAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Apixaban. Specifically, the risk for bleeding may be increased.
ArgatrobanMay enhance the anticoagulant effect of Anticoagulants.
BenazeprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
Bismuth SubsalicylateMay enhance the anticoagulant effect of other Salicylates.
BivalirudinMay enhance the anticoagulant effect of Anticoagulants.
BromocriptineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
BumetanideMay diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.
CanagliflozinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
CaptoprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
CarisoprodolAspirin may increase serum concentrations of the active metabolite(s) of Carisoprodol. Specifically, Meprobamate concentrations may be increased. Aspirin may decrease the serum concentration of Carisoprodol.
ChlorpropamideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
CilazaprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
CilostazolAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
CitalopramAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
Citric AcidAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
ClopidogrelAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
CorticotropinMay enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.
Cortisone acetateMay enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.
Dabigatran etexilateAgents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.
DalteparinAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
DanaparoidMay enhance the anticoagulant effect of Anticoagulants.
DapagliflozinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
DasatinibMay enhance the anticoagulant effect of Agents with Antiplatelet Properties.
Deoxycholic AcidAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Deoxycholic Acid. Specifically, the risk for bleeding or bruising in the treatment area may be increased.
DesvenlafaxineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
DiclofenamideSalicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination. Exceptions: Brinzolamide; Dorzolamide.
DicoumarolAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
DiflunisalNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
DiltiazemCalcium Channel Blockers (Nondihydropyridine) may enhance the anticoagulant effect of Salicylates.
DipyridamoleAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
DisopyramideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
DulaglutideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
DuloxetineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
Edetic AcidAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
EmpagliflozinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
EnalaprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
EnoxaparinAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
EptifibatideAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
EscitalopramAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
Ethacrynic acidMay diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.
EthoxzolamideSalicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination. Exceptions: Brinzolamide; Dorzolamide.
Ethyl biscoumacetateAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
EtodolacNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
ExenatideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
FenoprofenNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
FloctafenineMay enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Floctafenine may diminish the cardioprotective effect of Aspirin.
FludrocortisoneMay enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.
FluoxetineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
FluvoxamineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
Fondaparinux sodiumMay enhance the anticoagulant effect of Anticoagulants.
FosinoprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
FurosemideMay diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.
Ginkgo bilobaMay enhance the anticoagulant effect of Salicylates.
GliclazideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
GlimepirideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
GlipizideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
GlucosamineMay enhance the antiplatelet effect of Agents with Antiplatelet Properties.
GlyburideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
HeparinAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
HyaluronidaseMay diminish the therapeutic effect of Hyaluronidase.
IbritumomabAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.
IbuprofenNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
IndomethacinNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
inhaled insulinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin AspartMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin DetemirMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin GlargineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin GlulisineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin LisproMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Insulin RegularMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
KetoprofenNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
KetorolacNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
LanreotideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
LevomilnacipranAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
LinagliptinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
LiraglutideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
LisinoprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
Magnesium salicylateMay enhance the anticoagulant effect of other Salicylates.
MecaserminMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Mefenamic acidNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
MeloxicamNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
MetforminMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
MethazolamideMay enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.
MethotrexateMay increase the serum concentration of Methotrexate. Salicylate doses used for prophylaxis of cardiovascular events are not likely to be of concern.
MethylprednisoloneMay enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.
MifepristoneMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
MiglitolMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
MilnacipranAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
MoexiprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
NabumetoneNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
NadroparinMay enhance the anticoagulant effect of Anticoagulants.
NaproxenNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
NateglinideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
ObinutuzumabAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Obinutuzumab. Specifically, the risk of serious bleeding-related events may be increased.
OctreotideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
OxaprozinNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
ParoxetineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
PasireotideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
PentamidineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
PentoxifyllineMay enhance the antiplatelet effect of Agents with Antiplatelet Properties.
PerindoprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
PhenindioneAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
PhenprocoumonAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
PioglitazoneMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
PiroxicamNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
PralatrexateSalicylates may increase the serum concentration of PRALAtrexate. Salicylate doses used for prophylaxis of cardiovascular events are unlikely to be of concern.
PramlintideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
PrasugrelAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
PrednisoneMay enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.
ProbenecidSalicylates may diminish the therapeutic effect of Probenecid.
QuinaprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
QuinineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
RamiprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
RepaglinideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
ReteplaseMay enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.
RidogrelAgents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.
RivaroxabanAgents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.
RosiglitazoneMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
Salicylate-sodiumAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
SalsalateMay enhance the anticoagulant effect of other Salicylates.
SaxagliptinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
SertralineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
SitagliptinMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
StreptokinaseAgents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.
SulfadiazineMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
SulfamethoxazoleMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
SulfisoxazoleMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
SulindacNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
SulodexideAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
SunitinibMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
TenecteplaseMay enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.
Tiaprofenic acidNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
TicagrelorAspirin may enhance the antiplatelet effect of Ticagrelor. Aspirin may diminish the therapeutic effect of Ticagrelor. More specifically, the benefits of ticagrelor relative to clopidogrel may be diminished in patients receiving daily aspirin doses greater than 100-150 mg daily.
TiclopidineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
TiludronateAspirin may decrease the serum concentration of Tiludronate.
TinzaparinMay enhance the anticoagulant effect of Anticoagulants.
TipranavirMay enhance the antiplatelet effect of Agents with Antiplatelet Properties.
TirofibanAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
TolazamideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
TolbutamideMay enhance the hypoglycemic effect of Blood Glucose Lowering Agents.
TolmetinNSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective). Exceptions: Choline Magnesium Trisalicylate.
TopiramateMay enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.
TorasemideMay diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.
TrandolaprilMay diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
TreprostinilTreprostinil may enhance the adverse/toxic effect of Salicylates. Bleeding may occur.
UrokinaseAgents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.
Valproic AcidMay increase the serum concentration of Valproic Acid and Derivatives.
VenlafaxineAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
VilazodoneAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
Vitamin EMay enhance the antiplatelet effect of Agents with Antiplatelet Properties.
VorapaxarAgents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.
WarfarinAgents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.
ZonisamideMay enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.
Food Interactions
  • Avoid alcohol, alcohol appears to cause a 50 to 100% increases in ASA serum levels.
  • Take with a full glass of water.
  • Take with food to reduce gastric irritation.

Targets

1. Prostaglandin G/H synthase 1

Kind: protein

Organism: Human

Pharmacological action: yes

Actions: inhibitor

Components

Name UniProt ID Details
Prostaglandin G/H synthase 1 P23219 Details

References:

  1. Stevenson DD, Szczeklik A: Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006 Oct;118(4):773-86; quiz 787-8. Epub 2006 Sep 1. Pubmed
  2. Flipo RM: [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?] Presse Med. 2006 Sep;35(9 Spec No 1):1S53-60. Pubmed
  3. Schwartz KA: Aspirin resistance: a review of diagnostic methodology, mechanisms, and clinical utility. Adv Clin Chem. 2006;42:81-110. Pubmed
  4. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF: Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat. 2007 Feb;83(1-2):89-98. Epub 2006 Nov 7. Pubmed
  5. Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF, Kleiman NS: Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost. 2007 Mar;5(3):490-6. Pubmed
  6. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. Pubmed

2. Prostaglandin G/H synthase 2

Kind: protein

Organism: Human

Pharmacological action: yes

Actions: inhibitor

Components

Name UniProt ID Details
Prostaglandin G/H synthase 2 P35354 Details

References:

  1. Brzozowski T, Konturek PC, Sliwowski Z, Kwiecien S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW: Interaction of nonsteroidal anti – inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physiol Pharmacol. 2006 Sep;57 Suppl 3:67-79. Pubmed
  2. Wang HJ, Liu XJ, Yang KX, Luo FM, Lou JY, Peng ZL: [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell] Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Sep;37(5):757-60. Pubmed
  3. Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM: Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk. Breast Cancer Res. 2006;8(6):R71. Pubmed
  4. Nakano M, Denda N, Matsumoto M, Kawamura M, Kawakubo Y, Hatanaka K, Hiramoto Y, Sato Y, Noshiro M, Harada Y: Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation. Eur J Pharmacol. 2007 Mar 22;559(2-3):210-8. Epub 2006 Dec 16. Pubmed
  5. Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, Willett WC, Ma J: Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):314-21. Pubmed
  6. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. Pubmed

3. Aldo-keto reductase family 1 member C1

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: inhibitor

Components

Name UniProt ID Details
Aldo-keto reductase family 1 member C1 Q04828 Details

References:

  1. Dhagat U, Carbone V, Chung RP, Matsunaga T, Endo S, Hara A, El-Kabbani O: A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase. Med Chem. 2007 Nov;3(6):546-50. Pubmed

4. 5'-AMP-activated protein kinase

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: activator

Components

Name UniProt ID Details
5'-AMP-activated protein kinase catalytic subunit alpha-1 Q13131 Details
5'-AMP-activated protein kinase catalytic subunit alpha-2 P54646 Details
5'-AMP-activated protein kinase subunit beta-1 Q9Y478 Details
5'-AMP-activated protein kinase subunit beta-2 O43741 Details
5'-AMP-activated protein kinase subunit gamma-1 P54619 Details
5'-AMP-activated protein kinase subunit gamma-2 Q9UGJ0 Details
5'-AMP-activated protein kinase subunit gamma-3 Q9UGI9 Details

References:

  1. Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG: Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012 Jun;142(7):1504-15.e3. doi: 10.1053/j.gastro.2012.02.050. Epub 2012 Mar 6. Pubmed
  2. Raffensperger, Lisa (19 April 2012). Clues to aspirin’s anti-cancer effects revealed. New Scientist 214 (2862): 16. doi:10.1016/S0262-4079(12)61073-2.
  3. Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG: The ancient drug salicylate directly activates AMP-activated protein kinase. Science. 2012 May 18;336(6083):918-22. doi: 10.1126/science.1215327. Epub 2012 Apr 19. Pubmed

5. Endothelin-1 receptor

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
Endothelin-1 receptor P25101 Details

References:

  1. Talbodec A, Berkane N, Blandin V, Breittmayer JP, Ferrari E, Frelin C, Vigne P: Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism. Mol Pharmacol. 2000 Apr;57(4):797-804. Pubmed

6. Inhibitor of nuclear factor kappa-B kinase subunit beta

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
Inhibitor of nuclear factor kappa-B kinase subunit beta O14920 Details

References:

  1. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998 Nov 5;396(6706):77-80. Pubmed

7. Cellular tumor antigen p53

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: acetylation

Components

Name UniProt ID Details
Cellular tumor antigen p53 P04637 Details

References:

  1. Alfonso LF, Srivenugopal KS, Bhat GJ: Does aspirin acetylate multiple cellular proteins? (Review). Mol Med Rep. 2009 Jul-Aug;2(4):533-7. doi: 10.3892/mmr_00000132. Pubmed

8. 78 kDa glucose-regulated protein

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: binding

Components

Name UniProt ID Details
78 kDa glucose-regulated protein P11021 Details

References:

  1. Deng WG, Ruan KH, Du M, Saunders MA, Wu KK: Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts. FASEB J. 2001 Nov;15(13):2463-70. Pubmed

9. Ribosomal protein S6 kinase alpha-3

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
Ribosomal protein S6 kinase alpha-3 P51812 Details

References:

  1. Stevenson MA, Zhao MJ, Asea A, Coleman CN, Calderwood SK: Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. J Immunol. 1999 Nov 15;163(10):5608-16. Pubmed

10. NF-kappa-B inhibitor alpha

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
NF-kappa-B inhibitor alpha P25963 Details

References:

  1. Stevenson MA, Zhao MJ, Asea A, Coleman CN, Calderwood SK: Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes. J Immunol. 1999 Nov 15;163(10):5608-16. Pubmed

11. Nuclear factor NF-kappa-B

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: antagonist

Components

Name UniProt ID Details
Nuclear factor NF-kappa-B p100 subunit Q00653 Details
Nuclear factor NF-kappa-B p105 subunit P19838 Details

References:

  1. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994 Aug 12;265(5174):956-9. Pubmed

Enzymes

1. Cytochrome P450 2C19

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: inducer

Components

Name UniProt ID Details
Cytochrome P450 2C19 P33261 Details

References:

  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. Epub 2009 Nov 24. Pubmed

2. Cytochrome P450 2C8

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: substrate

Components

Name UniProt ID Details
Cytochrome P450 2C8 P10632 Details

References:

  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. Epub 2009 Nov 24. Pubmed

3. Cytochrome P450 2C9

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: substrate

Components

Name UniProt ID Details
Cytochrome P450 2C9 P11712 Details

References:

  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. Epub 2009 Nov 24. Pubmed

Carriers

1. Serum albumin

Kind: protein

Organism: Human

Pharmacological action: no

Actions: other/unknown

Components

Name UniProt ID Details
Serum albumin P02768 Details

References:

  1. Sulkowska A, Bojko B, Rownicka J, Sulkowski WW: Competition of cytarabine and aspirin in binding to serum albumin in multidrug therapy. Biopolymers. 2006 Apr 15;81(6):464-72. Pubmed
  2. Dundee JW, Halliday NJ, McMurray TJ: Aspirin and probenecid pretreatment influences the potency of thiopentone and the onset of action of midazolam. Eur J Anaesthesiol. 1986 May;3(3):247-51. Pubmed

Transporters

1. Solute carrier family 22 member 6

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: inhibitor

Components

Name UniProt ID Details
Solute carrier family 22 member 6 Q4U2R8 Details

References:

  1. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H: Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol. 1999 May;55(5):847-54. Pubmed

2. Multidrug resistance protein 1

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: substrate

Components

Name UniProt ID Details
Multidrug resistance protein 1 P08183 Details

References:

  1. Faassen F, Vogel G, Spanings H, Vromans H: Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22. Pubmed

3. Solute carrier family 22 member 7

Kind: protein

Organism: Human

Pharmacological action: unknown

Actions: substrate

Components

Name UniProt ID Details
Solute carrier family 22 member 7 Q9Y694 Details

References:

  1. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H: Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998 Jun 12;429(2):179-82. Pubmed

Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:12